Nash ICD-10-CM Codes
Explore ICD-10-CM codes for Nonalcoholic Steatohepatitis (NASH) in 2023. Learn about common codes, billable statuses, and gain clinical insights in this comprehensive guide.
Fact Checked by Nate Lacson.
What ICD-10 Codes are Used for Nash?
Nonalcoholic Steatohepatitis (NASH) is a liver disease characterized by fat accumulation in the liver and inflammation. Here are ten commonly used ICD-10-CM codes for NASH, along with brief clinical descriptions:
- K75.81 - Nonalcoholic steatohepatitis (NASH): Used for cases of NASH, which is characterized by liver inflammation and fat accumulation due to causes other than alcohol.
- K76.0 - Fatty (change of) liver, not elsewhere classified: Applied when fatty liver disease, including NASH, is diagnosed but without further specification.
- K75.89 - Other specified inflammatory liver diseases: Utilized for other specific inflammatory liver diseases, which may include NASH in some cases.
- E83.29 - Other hyperalimentation: Used when NASH is associated with overnutrition or other metabolic conditions.
- E78.5 - Hyperlipidemia, unspecified: Applied when NASH is associated with high levels of lipids (fats) in the blood, which is common in these patients.
- K76.89 - Other specified diseases of the liver: Utilized when NASH is diagnosed but is not classified under a more specific code.
- E61.5 - Hyperhomocysteinemia due to unspecified B group vitamin deficiency: Used for NASH cases associated with elevated homocysteine levels due to unspecified B vitamin deficiency.
- E66.9 - Obesity, unspecified: Applied for NASH cases associated with obesity but without specifying the degree or type.
- K76.9 - Liver disease, unspecified: Utilized for cases where liver disease is diagnosed but the specific liver condition is unspecified.
- K76.4 - Peliosis hepatis: Used when NASH is complicated by peliosis hepatis, a rare condition involving blood-filled cysts in the liver.
Which Nash ICD Codes are Billable?
The billable status of the mentioned ICD-10 codes for NASH varies
- K75.81 - Nonalcoholic steatohepatitis (NASH): Yes, billable. Medical expenses related to NASH can be claimed.
- K76.0 - Fatty (change of) liver, not elsewhere classified: Not typically billable on its own. Additional details are required for billing.
- K75.89 - Other specified inflammatory liver diseases: Yes, billable. Costs associated with other specific inflammatory liver diseases, including NASH, can be reimbursed.
- E83.29 - Other hyperalimentation: Not typically billable for NASH alone. It may be billable when associated with other conditions.
- E78.5 - Hyperlipidemia, unspecified: Not typically billable for NASH alone. It may be billable when hyperlipidemia is a significant part of the diagnosis.
- K76.89 - Other specified diseases of the liver: Yes, billable. Medical expenses for other specific liver diseases, including NASH, can be claimed.
- E61.5 - Hyperhomocysteinemia due to unspecified B group vitamin deficiency: Not typically billable for NASH alone. It may be billable when associated with other conditions.
- E66.9 - Obesity, unspecified: Not typically billable for NASH alone. It may be billable when obesity is a significant part of the diagnosis.
- K76.9 - Liver disease, unspecified: Not typically billable for NASH alone. It may be billable when associated with other conditions.
- K76.4 - Peliosis hepatis: Yes, billable. Medical expenses for NASH complicated by peliosis hepatis can be claimed.
Clinical Information
- Nonalcoholic Steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD) characterized by inflammation and damage.
- NASH is often associated with metabolic conditions such as obesity, type 2 diabetes, and high cholesterol.
- Diagnosis involves a combination of clinical evaluation, imaging (ultrasound, CT, MRI), and liver biopsy.
- Management strategies include lifestyle modifications, such as weight loss, dietary changes, and increased physical activity.
- Medications may be considered to manage risk factors and comorbid conditions like diabetes.
- Regular monitoring is essential to assess liver function and disease progression.
- Progression of NASH can lead to cirrhosis and liver failure, making early diagnosis and intervention critical.
- Healthcare practitioners should educate patients on adherence to treatment plans, lifestyle changes, and regular follow-up to manage NASH effectively.
Synonyms Include
- Nonalcoholic Steatohepatitis
- NASH Liver Disease
- Fatty Liver Disease
- Inflammatory Liver Disease
- Liver Inflammation
- NASH ICD-10
Commonly asked questions
What are the common symptoms of NASH?
Common symptoms of NASH include fatigue, abdominal discomfort, and an enlarged liver. However, many individuals with NASH may not have noticeable symptoms until the disease progresses.
How is NASH treated?
Treatment for NASH involves lifestyle changes such as weight loss, a healthy diet, exercise, and managing underlying conditions like diabetes and high cholesterol. In some cases, medications may be prescribed.
Can NASH lead to liver cirrhosis?
Yes, NASH can progress to cirrhosis, which is advanced liver scarring. Regular medical evaluation and lifestyle changes are crucial to prevent this progression.
Related Guides
Join 10,000+ teams using Carepatron to be more productive
One app for all your healthcare work